mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.007 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.007 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.007 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.007 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.007 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.008 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.008 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.009 |